**Inhibition of Protein Phosphatase 2A Enhances Mcl-1 Degradation by Sustaining Phosphorylation at the Thr-163/Ser-159 Phosphodegron in Chemoresistant Lymphoma Cells**

The regulation of Mcl-1 stability is a critical determinant of cancer cell survival and resistance to chemotherapy. This study demonstrates that inhibition of protein phosphatase 2A (PP2A) leads to sustained phosphorylation of Mcl-1 at Thr-163 and Ser-159, key residues within a PEST region–associated phosphodegron. In Mcl-1-amplified BL41-3 Burkitt lymphoma cells, treatment with the PP2A inhibitor okadaic acid rapidly increased phosphorylation at both sites, accompanied by a dramatic reduction in total Mcl-1 protein levels. This effect occurred independently of ERK activation, as evidenced by the persistence of elevated phosphorylation even when ERK signaling was blocked by U0126.Thiophene-3,4-dicarboxylic acid supplier Furthermore, the dephosphorylation-dependent stabilization of Mcl-1 was confirmed using calyculin A, another potent PP2A inhibitor, which mirrored the effects of okadaic acid. In contrast, tautomycin, which preferentially inhibits PP1 over PP2A, failed to induce significant changes in Mcl-1 phosphorylation or expression. Co-immunoprecipitation and GST pulldown assays revealed a direct physical interaction between Mcl-1 and the PP2A holoenzyme, specifically involving the catalytic subunit (PP2A/C) and scaffolding subunit (PP2A/A).3-Ethyl-2-hydroxy-2-cyclopenten-1-one Biochemical Assay Reagents Knockdown of PP2A/A via shRNA recapitulated the phenotype: increased phosphorylation at Thr-163 and Ser-159, coupled with decreased Mcl-1 expression.PMID:34553229 Notably, these changes preceded the appearance of apoptotic markers such as PARP cleavage and morphological alterations, indicating that Mcl-1 degradation is an early event rather than a consequence of cell death. The presence of phorbol ester (TPA), known to stabilize Mcl-1 through ERK activation, did not rescue Mcl-1 levels upon PP2A inhibition, underscoring the dominant role of dephosphorylation in maintaining Mcl-1 abundance. These findings establish that PP2A-mediated dephosphorylation acts as a molecular switch protecting Mcl-1 from degradation. By blocking this dephosphorylation step, pharmacological or genetic inhibition of PP2A can override oncogenic stabilization mechanisms and trigger rapid loss of this prosurvival protein, offering a promising therapeutic strategy for targeting chemoresistant cancers dependent on high Mcl-1 expression.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com